bf/NASDAQ:IDRA_icon.jpeg

NASDAQ:IDRA

Idera Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.55

17/01 21:00

Volume Today

371.88K

Avg: 34.02K

PE Ratio

−0.06

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
revenue
47K
-
73K
55.32%
249K
241.10%
16.20M
6,405.62%
902K
94.43%
662K
26.61%
1.45M
118.73%
cost of revenue
gross profit
47K
-
73K
55.32%
249K
241.10%
16.20M
6,405.62%
902K
94.43%
662K
26.61%
1.45M
118.73%
selling and marketing expenses
general and administrative expenses
7.74M
-
11.33M
46.39%
15.40M
35.86%
15.13M
1.71%
16.72M
10.47%
15.42M
7.75%
12.48M
19.06%
11.91M
4.53%
9.98M
16.27%
12.21M
22.42%
selling general and administrative expenses
7.74M
-
11.33M
46.39%
15.40M
35.86%
15.13M
1.71%
16.72M
10.47%
15.42M
7.75%
12.48M
19.06%
11.91M
4.53%
9.98M
16.27%
12.21M
22.42%
research and development expenses
10.47M
-
27.49M
162.46%
33.70M
22.57%
39.82M
18.18%
50.65M
27.19%
41.84M
17.40%
34.85M
16.70%
24.77M
28.92%
16.38M
33.90%
12.19M
25.57%
other expenses
4.36M
-
181K
95.85%
1.32M
-
8.28M
526.25%
cost and expenses
18.22M
-
38.83M
113.14%
49.09M
26.45%
54.96M
11.94%
67.37M
22.59%
57.26M
15.00%
47.33M
17.34%
36.69M
22.49%
27.67M
24.57%
32.68M
18.09%
operating expenses
18.22M
-
38.83M
113.14%
49.09M
26.45%
54.96M
11.94%
67.37M
22.59%
57.26M
15.00%
47.33M
17.34%
36.69M
22.49%
27.67M
24.57%
32.68M
18.09%
interest expense
105K
-
80K
23.81%
50K
37.50%
11K
78%
3K
-
7K
133.33%
204K
2,814.29%
ebitda
-18.09M
-
-38.44M
112.48%
-47.96M
24.78%
-37.65M
21.49%
-65.19M
73.13%
-59.44M
8.82%
-56.40M
5.12%
-112.60M
99.66%
98.12M
187.14%
-27.82M
128.35%
operating income
-18.17M
-
-38.75M
113.29%
-48.85M
26.05%
-38.76M
20.65%
-66.47M
71.50%
-60.96M
8.29%
-46.07M
24.43%
-36.69M
20.36%
98.10M
367.39%
-29.47M
130.05%
depreciation and amortization
137K
-
206K
50.36%
488K
136.89%
656K
34.43%
746K
13.72%
432K
42.09%
120K
72.22%
61K
49.17%
22K
63.93%
1.66M
7,427.27%
total other income expenses net
-57K
-
110K
292.98%
291K
164.55%
368K
26.46%
483K
31.25%
1.07M
122.57%
-10.45M
1,071.91%
-75.97M
627.17%
-7K
99.99%
-204K
2,814.29%
income before tax
-18.23M
-
-38.64M
112.02%
-48.55M
25.65%
-38.39M
20.94%
-65.98M
71.88%
-59.88M
9.25%
-56.52M
5.62%
-112.66M
99.35%
98.09M
187.07%
-29.68M
130.26%
income tax expense
-57K
-
110K
292.98%
396K
260%
448K
13.13%
533K
18.97%
1.09M
103.75%
-10.45M
1,062.06%
-75.97M
627.14%
7K
100.01%
-6.32M
90,357.14%
net income
-18.23M
-
-38.64M
112.02%
-48.55M
25.65%
-38.39M
20.94%
-65.98M
71.88%
-59.88M
9.25%
-56.52M
5.62%
-112.66M
99.35%
98.08M
187.06%
-23.36M
123.82%
weighted average shs out
322.84K
-
609.02K
88.65%
846.26K
38.95%
938.21K
10.87%
1.16M
23.36%
1.56M
35.20%
1.68M
7.31%
1.99M
18.48%
1.99M
0%
3.26M
63.64%
weighted average shs out dil
322.84K
-
609.02K
88.65%
846.26K
38.95%
938.21K
10.87%
1.16M
23.36%
1.56M
35.20%
1.68M
7.31%
1.99M
18.48%
1.99M
0%
3.26M
63.64%
eps
-56.46
-
-63.45
12.38%
-57.38
9.57%
-40.92
28.69%
-57.01
39.32%
-38.27
32.87%
-33.66
12.05%
-56.63
68.24%
49.30
187.06%
-7.18
114.56%
epsdiluted
-56.46
-
-63.45
12.38%
-57.38
9.57%
-40.92
28.69%
-57.01
39.32%
-38.27
32.87%
-33.66
12.05%
-56.63
68.24%
49.30
187.06%
-7.18
114.56%

All numbers in USD (except ratios and percentages)